| Apafant | IC50 | 40.0 [1], 50.0 [2], 200.0 [3] |
| 2-[3-Methoxy-2-propoxy-5-[(2S,5S)-5-(3,4,5-trimethoxyphenyl)oxolan-2-yl]phenyl]sulfonylethanol | IC50 | 6.0 [1] |
| 2-[3-Methoxy-2-propoxy-5-[(2S,5S)-5-(3,4,5-trimethoxyphenyl)oxolan-2-yl]phenyl]sulfonylethanol | Ki | 3.2 [1], 6.0 [2], 6.1 [3], 6.3 [4] |
| (2R,5R)-2-(3-Methoxy-5-methylsulfonyl-4-propoxyphenyl)-5-(3,4,5-trimethoxyphenyl)oxolane | IC50 | 13.0 [1] |
| (2R,5R)-2-(3-Methoxy-5-methylsulfonyl-4-propoxyphenyl)-5-(3,4,5-trimethoxyphenyl)oxolane | Ki | 9.0 [1], 14.3 [2] |
| 5-(4-Methoxyphenyl)-N-(1-methyl-4-(3-pyridinyl)butyl)-2,4-decadienamide | IC50 | 40.0 [1] |
| Loratadine | IC50 | 50000.0 [1], 135000.0 [2] |
| Modipafant racemate | IC50 | 13.0 [1], 31.3 [2] |
| Respatadine | IC50 | 610.0 [1], 840.0 [2] |
| 5-[4-[2-(3,4,5-Trimethoxyphenyl)ethyl]phenyl]-2,3-dihydroimidazo[2,1-a]isoquinoline | IC50 | 40.0 [1], 60.0 [2] |
| (2R,5R)-2,5-Bis(3,4,5-trimethoxyphenyl)oxolane | IC50 | 1500.0 [1] |
| (2R,5R)-2,5-Bis(3,4,5-trimethoxyphenyl)oxolane | Ki | 103.0 [1] |
| 2-[3-Methoxy-2-propoxy-5-[5-(3,4,5-trimethoxyphenyl)oxolan-2-yl]phenyl]sulfonylethanol | Ki | 59.0 [1], 116.0 [2] |
| 4-(2-Chlorophenyl)-2-iodo-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine | IC50 | 370.0 [1] |
| 1-Iphtf | Ki | 1.85 [1], 2.9 [2] |
| Potassium;3-[3-(2-oxopropylsulfonyl)-2-propoxy-5-[(2S,5S)-5-(3,4,5-trimethoxyphenyl)oxolan-2-yl]phenoxy]propyl hydrogen phosphate | Ki | 110.0 [1], 174.0 [2] |
| (4R)-5-[3-Methoxy-2-propoxy-5-[(2S,5S)-5-(3,4,5-trimethoxyphenyl)oxolan-2-yl]phenyl]sulfonyl-4-methylpentan-1-ol | Ki | 3.72 [1], 5.26 [2] |
| (4S)-5-[3-Methoxy-2-propoxy-5-[(2S,5S)-5-(3,4,5-trimethoxyphenyl)oxolan-2-yl]phenyl]sulfonyl-4-methylpentan-1-ol | Ki | 2.86 [1], 3.7 [2] |
| N-Cyclohexyl-N-methyl-4-[(2-methylbenzimidazol-1-yl)methyl]benzenesulfonamide | IC50 | 300.0 [1] |
| (5S)-2-[4-[2-(Benzenesulfonyl)ethoxy]-3-methoxy-5-propylsulfonylphenyl]-5-(3,4,5-trimethoxyphenyl)oxolane | IC50 | 1.0 [1] |
| (5S)-2-[4-[2-(Benzenesulfonyl)ethoxy]-3-methoxy-5-propylsulfonylphenyl]-5-(3,4,5-trimethoxyphenyl)oxolane | Ki | 1.0 [1] |
| Clotrimazole | Ki | 22635.0 [1] |
| Chlorpheniramine | IC50 | 50000.0 [1] |
| Ginkgolide-B | IC50 | 128.0 [1] |
| Brotizolam | IC50 | 300.0 [1] |
| Cilostamide | Ki | 1917.0 [1] |
| Rupatadine | IC50 | 3700.0 [1] |
| Azatadine | IC50 | 50000.0 [1] |
| Lexipafant | Ki | 0.38 [1] |
| 5-[3-[7-(2-Chlorophenyl)-13-methyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaen-4-yl]prop-2-ynyl]phenanthridin-6-one | IC50 | 13.0 [1] |
| Tulopafantum | IC50 | 11.0 [1] |
| Orvepitant | Ki | 2270.0 [1] |
| (2r)-2-(Acetyloxy)-3-(Hexadecyloxy)propyl 2-(Trimethylammonio)ethyl Phosphate | IC50 | 0.28 [1] |
| 3-[[2-[2-(4-Chlorophenyl)sulfanylethoxy]-3-methoxy-5-[(2S,5S)-5-(3,4,5-trimethoxyphenyl)oxolan-2-yl]phenyl]methyl]-1-hydroxy-1-methylurea | IC50 | 10.0 [1] |
| [4-(3-Phenylpropyl)piperazin-1-yl]-[(4R)-2-pyridin-3-yl-1,3-thiazolidin-4-yl]methanone | IC50 | 2.3 [1] |
| CID 46897162 | IC50 | 5000.0 [1] |
| 1-[4-(13-Chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-ylidene)piperidin-1-yl]butan-1-one | IC50 | 33000.0 [1] |
| 1-[4-(13-Chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-ylidene)piperidin-1-yl]propan-1-one | IC50 | 2400.0 [1] |
| N-(4-1H-Imidazol-1-yl)butyl-2-(1-methylethyl)-11-oxo-11H-pyrido(2,1b)quinazoline-8-carboxamide | IC50 | 3500.0 [1] |
| ABT-491 free base | Ki | 0.57 [1] |
| (2R,3R,4R,5S)-2,5-Bis-(3,4-dimethoxy-phenyl)-3,4-dimethyl-tetrahydro-furan | Ki | 1000.0 [1] |
| N-[(2S)-1-Ethoxy-4-methylpentan-2-yl]-4-[(2-methylimidazo[4,5-c]pyridin-1-yl)methyl]benzenesulfonamide | IC50 | 0.01 [1] |
| 5-(2-Fluoro-phenyl)-2,3-dihydro-imidazo[2,1-a]isoquinoline | IC50 | 5700.0 [1] |
| 11-Oxo-2-propan-2-yl-N-(4-pyridin-3-ylbutyl)pyrido[2,1-b]quinazoline-8-carboxamide | IC50 | 350.0 [1] |
| 2-Methyl-11-oxo-N-(4-pyridin-3-ylbutyl)pyrido[2,1-b]quinazoline-8-carboxamide | IC50 | 500.0 [1] |
| 2-Methoxy-11-oxo-N-(4-pyridin-3-ylbutyl)pyrido[2,1-b]quinazoline-8-carboxamide | IC50 | 1000.0 [1] |
| 11-Oxo-2-propan-2-yloxy-N-(4-pyridin-3-ylbutyl)pyrido[2,1-b]quinazoline-8-carboxamide | IC50 | 600.0 [1] |
| 11-Oxo-N-(4-pyridin-3-ylbutyl)pyrido[2,1-b]quinazoline-8-carboxamide | IC50 | 1800.0 [1] |
| 2-Bromo-11-oxo-N-(4-pyridin-3-ylbutyl)pyrido[2,1-b]quinazoline-8-carboxamide | IC50 | 700.0 [1] |
| 2-Hydroxy-11-oxo-N-(4-pyridin-3-ylbutyl)pyrido[2,1-b]quinazoline-8-carboxamide | IC50 | 1200.0 [1] |
| 11-Oxo-2-propan-2-yl-N-(4-pyridin-2-ylbutyl)pyrido[2,1-b]quinazoline-8-carboxamide | IC50 | 5000.0 [1] |
| 11-Oxo-2-propan-2-yl-N-(7-pyridin-3-ylheptyl)pyrido[2,1-b]quinazoline-8-carboxamide | IC50 | 1000.0 [1] |
| 11-Oxo-2-propan-2-yl-N-(4-pyrimidin-5-ylbutyl)pyrido[2,1-b]quinazoline-8-carboxamide | IC50 | 450.0 [1] |
| 3-Methoxy-11-oxo-N-(4-pyridin-3-ylbutyl)pyrido[2,1-b]quinazoline-8-carboxamide | IC50 | 370.0 [1] |
| 3-Chloro-11-oxo-N-(4-pyridin-3-ylbutyl)pyrido[2,1-b]quinazoline-8-carboxamide | IC50 | 1000.0 [1] |
| N-(2-Methyl-5-pyridin-3-ylpentan-2-yl)-11-oxo-2-propan-2-ylpyrido[2,1-b]quinazoline-8-carboxamide | IC50 | 1200.0 [1] |
| N-Formyl Desloratadine | IC50 | 13000.0 [1] |
| 1-[4-(13-Methoxy-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-ylidene)piperidin-1-yl]ethanone | IC50 | 3400.0 [1] |
| 1-[4-(2-Tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaenylidene)piperidin-1-yl]ethanone | IC50 | 41000.0 [1] |
| 2,5-Bis-(3,4,5-trimethoxy-phenyl)-tetrahydro-furan | IC50 | 180.0 [1] |
| 1-(2,2-Dimethylpropyl)-5-[5-(2-hydroxypropan-2-yl)-2-methylphenyl]-3-methylimidazo[4,5-b]pyridin-2-one | Ki | 2000.0 [1] |
| SDZ-62-434 free | IC50 | 7500.0 [1] |
| N-[4,6-Dimethoxy-2-(3-morpholin-4-ylpropylamino)pyrimidin-5-yl]-5-[(3,3,6-trimethyl-1,2-dihydroinden-5-yl)oxy]furan-2-carboxamide | Ki | 1060.0 [1] |
| (E)-3-(1-Butyl-4-methoxynaphthalen-2-yl)-N-[(2S)-5-pyridin-3-ylpentan-2-yl]prop-2-enamide | IC50 | 1.0 [1] |
| 5-p-Tolyl-2,3-dihydro-imidazo[2,1-a]isoquinoline | IC50 | 5400.0 [1] |
| Diallyl-[4-(2,3-dihydro-imidazo[2,1-a]isoquinolin-5-yl)-benzyl]-amine | IC50 | 9200.0 [1] |
| 4-[[4-(2,3-Dihydroimidazo[2,1-a]isoquinolin-5-yl)phenyl]methyl]thiomorpholine | IC50 | 1100.0 [1] |
| 1-[3-(3-Morpholin-4-ylpropoxy)-2-propoxy-5-[(2S,5S)-5-(3,4,5-trimethoxyphenyl)oxolan-2-yl]phenyl]sulfonylpropan-2-one | Ki | 2.5 [1] |
| 5-(4-Pyrrolidin-1-ylmethyl-phenyl)-2,3-dihydro-imidazo[2,1-a]isoquinoline | IC50 | 59400.0 [1] |
| Dicyclohexyl-[4-(2,3-dihydro-imidazo[2,1-a]isoquinolin-5-yl)-benzyl]-amine | IC50 | 13100.0 [1] |
| 5-Phenyl-2,3-dihydroimidazo[2,1-a]isoquinoline | IC50 | 11200.0 [1] |
| 5-Pyridin-4-yl-2,3-dihydro-imidazo[2,1-a]isoquinoline | IC50 | 47900.0 [1] |
| 5-Thiophen-2-yl-2,3-dihydro-imidazo[2,1-a]isoquinoline | IC50 | 15200.0 [1] |
| 5-(3,4-Dimethoxy-phenyl)-2,3-dihydro-imidazo[2,1-a]isoquinoline | IC50 | 22000.0 [1] |
| 5-(4-Tert-Butylphenyl)-2,3-dihydroimidazo[2,1-a]isoquinoline | IC50 | 900.0 [1] |
| 5-(4-Morpholin-4-ylmethyl-phenyl)-2,3-dihydro-imidazo[2,1-a]isoquinoline | IC50 | 2800.0 [1] |
| 5-Furan-2-yl-2,3-dihydro-imidazo[2,1-a]isoquinoline | IC50 | 100000.0 [1] |
| 5-(4-Fluoro-phenyl)-2,3-dihydro-imidazo[2,1-a]isoquinoline | IC50 | 14200.0 [1] |
| 5-(3,4,5-Trimethoxy-phenyl)-2,3-dihydro-imidazo[2,1-a]isoquinoline | IC50 | 100000.0 [1] |
| 5-(4-Chloro-phenyl)-2,3-dihydro-imidazo[2,1-a]isoquinoline | IC50 | 37200.0 [1] |
| 5-Biphenyl-4-yl-2,3-dihydro-imidazo[2,1-a]isoquinoline | IC50 | 3400.0 [1] |
| 5-(2-Chloro-phenyl)-2,3-dihydro-imidazo[2,1-a]isoquinoline | IC50 | 8100.0 [1] |
| 5-(3-Chloro-phenyl)-2,3-dihydro-imidazo[2,1-a]isoquinoline | IC50 | 5400.0 [1] |
| 5-(4-Tert-butylphenyl)-9-methyl-2,3-dihydroimidazo[2,1-a]isoquinoline | IC50 | 31800.0 [1] |
| 1-[3-(3-Imidazol-1-ylpropoxy)-2-propoxy-5-[(2S,5S)-5-(3,4,5-trimethoxyphenyl)oxolan-2-yl]phenyl]sulfonylpropan-2-one | Ki | 3.0 [1] |
| 5-(4-Ethyl-phenyl)-2,3-dihydro-imidazo[2,1-a]isoquinoline | IC50 | 6300.0 [1] |
| 5-(4-Tert-butylphenyl)-9-chloro-2,3-dihydroimidazo[2,1-a]isoquinoline | IC50 | 40400.0 [1] |
| 5-Pyridin-3-yl-2,3-dihydro-imidazo[2,1-a]isoquinoline | IC50 | 100000.0 [1] |
| 5-(3,4-Dichloro-phenyl)-2,3-dihydro-imidazo[2,1-a]isoquinoline | IC50 | 17000.0 [1] |
| 5-(3-Trifluoromethyl-phenyl)-2,3-dihydro-imidazo[2,1-a]isoquinoline | IC50 | 19200.0 [1] |
| 3-[2-[2-(3-Bromophenyl)sulfanylethoxy]-3-methoxy-5-[(2S,5S)-5-(3,4,5-trimethoxyphenyl)oxolan-2-yl]phenyl]-1-butyl-1-hydroxyurea | IC50 | 22.0 [1] |
| 3-[2-[2-(4-Bromophenyl)sulfanylethoxy]-3-methoxy-5-[(2S,5S)-5-(3,4,5-trimethoxyphenyl)oxolan-2-yl]phenyl]-1-butyl-1-hydroxyurea | IC50 | 21.0 [1] |
| 1-Butyl-1-hydroxy-3-[3-methoxy-2-[2-(2,3,5,6-tetrafluorophenyl)sulfanylethoxy]-5-[(2S,5S)-5-(3,4,5-trimethoxyphenyl)oxolan-2-yl]phenyl]urea | IC50 | 2.0 [1] |
| 4-[2-(4-Butylphenyl)ethyl]-7-(2-chlorophenyl)-13-methyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaene | IC50 | 10.0 [1] |
| 3-[2-[2-(2-Bromophenyl)sulfanylethoxy]-3-methoxy-5-[(2S,5S)-5-(3,4,5-trimethoxyphenyl)oxolan-2-yl]phenyl]-1-butyl-1-hydroxyurea | IC50 | 23.0 [1] |
| 1-Butyl-1-hydroxy-3-[3-methoxy-2-[2-(2,3,5,6-tetrafluorophenyl)sulfonylethoxy]-5-[(2S,5S)-5-(3,4,5-trimethoxyphenyl)oxolan-2-yl]phenyl]urea | IC50 | 285.0 [1] |
| 1-Butyl-3-[[2-[2-(4-chlorophenyl)sulfanylethoxy]-3-methoxy-5-[(2S,5S)-5-(3,4,5-trimethoxyphenyl)oxolan-2-yl]phenyl]methyl]-1-hydroxyurea | IC50 | 167.0 [1] |
| 7-(2-Chlorophenyl)-13-methyl-4-[2-[4-(2-methylpropyl)phenyl]ethyl]-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaene | IC50 | 30.0 [1] |
| 3-[2-[2-(4-Bromophenyl)sulfonylethoxy]-3-methoxy-5-[(2S,5S)-5-(3,4,5-trimethoxyphenyl)oxolan-2-yl]phenyl]-1-butyl-1-hydroxyurea | IC50 | 38.0 [1] |
| 1-Butyl-3-[2-[2-(3,4-dichlorophenyl)sulfanylethoxy]-3-methoxy-5-[(2S,5S)-5-(3,4,5-trimethoxyphenyl)oxolan-2-yl]phenyl]-1-hydroxyurea | IC50 | 45.0 [1] |